| Stage | HSIC | % of rev | MDLN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.5B | 100.00% | $7.9B | 100.00% | MDLN ×2.26 |
| Gross profit | $1.1B | 31.84% | $1.9B | 24.50% | HSIC +7.3pp |
| Operating income | $193M | 5.56% | $500M | 6.36% | MDLN +0.8pp |
| Pre-tax income | $160M | 4.61% | $386M | 4.91% | MDLN +0.3pp |
| Net income | $126M | 3.63% | $318M | 4.05% | MDLN +0.4pp |
| Stage | HSIC | MDLN | Gap · A − B |
|---|---|---|---|
| Revenue | $3.5B100.00% | $7.9B100.00% | MDLN ×2.26 |
| Gross profit | 31.84%$1.1B | 24.50%$1.9B | HSIC +7.3pp |
| Operating income | 5.56%$193M | 6.36%$500M | MDLN +0.8pp |
| Pre-tax income | 4.61%$160M | 4.91%$386M | MDLN +0.3pp |
| Net income |
| 3.63%$126M |
| 4.05%$318M |
| MDLN +0.4pp |
No shared counterparties.